Detalhe da pesquisa
1.
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells.
Clin Infect Dis
; 76(12): 2200-2202, 2023 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883586
2.
Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.
Br J Haematol
; 202(6): 1165-1177, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37455345
3.
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
Haematologica
; 108(3): 690-704, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708137
4.
Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis.
Cancer
; 128(24): 4213-4222, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271776
5.
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia.
Haematologica
; 107(5): 1034-1044, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261293
6.
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
Blood
; 128(5): 686-98, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27288520
7.
Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older.
Haematologica
; 103(11): 1853-1861, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903761
8.
A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia.
Haematologica
; 103(3): 456-465, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242298
9.
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Eur J Haematol
; 100(2): 154-162, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29114972
10.
A fluorescence in situ hybridization-based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemia.
Genes Chromosomes Cancer
; 56(8): 632-638, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28420034
11.
Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.
Blood
; 122(10): 1761-9, 2013 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23878140
12.
Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients.
Blood
; 121(18): 3650-7, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23525797
13.
The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype.
Blood
; 119(19): 4383-6, 2012 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22374696
14.
High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia.
Blood
; 120(10): 2118-26, 2012 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22815426
15.
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
Blood
; 120(2): 395-403, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22649106
16.
Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.
Haematologica
; 99(8): 1317-25, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24816240
17.
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model.
J Hematol Oncol
; 17(1): 28, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702786
18.
A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma.
Eur J Cancer
; 196: 113436, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008033
19.
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.
Eur J Cancer
; 201: 113911, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377774
20.
Prognostic impact of CEBPA mutational subgroups in adult AML.
Leukemia
; 38(2): 281-290, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38228680